Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested Capital

Denali Therapeutics (DNLI) Asset Utilization Ratio (2018 - 2024)

Denali Therapeutics has reported Asset Utilization Ratio over the past 7 years, most recently at 0.0 for Q2 2024.

  • Quarterly Asset Utilization Ratio fell 99.67% to 0.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was 0.0 through Jun 2024, down 99.67% year-over-year, with the annual reading at 0.25 for FY2023, 233.91% up from the prior year.
  • Asset Utilization Ratio was 0.0 for Q2 2024 at Denali Therapeutics, down from 0.22 in the prior quarter.
  • Over five years, Asset Utilization Ratio peaked at 0.28 in Q4 2023 and troughed at 0.0 in Q2 2024.
  • The 5-year median for Asset Utilization Ratio is 0.09 (2022), against an average of 0.13.
  • Year-over-year, Asset Utilization Ratio surged 1008.5% in 2021 and then plummeted 99.67% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.25 in 2020, then crashed by 90.68% to 0.02 in 2021, then skyrocketed by 250.22% to 0.08 in 2022, then soared by 243.52% to 0.28 in 2023, then tumbled by 99.7% to 0.0 in 2024.
  • Per Business Quant, the three most recent readings for DNLI's Asset Utilization Ratio are 0.0 (Q2 2024), 0.22 (Q1 2024), and 0.28 (Q4 2023).